What Are We Learning from the FDA-Mandated Cardiovascular Outcome Studies for New Pharmacological Antidiabetic Agents?
Crossref DOI link: https://doi.org/10.1007/s11892-016-0788-5
Published Online: 2016-08-19
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lovre, Dragana
Htun, Wynn
Carrion, Carly
Fonseca, Vivian A.
License valid from 2016-08-19